SECTORAL ASSET MANAGEMENT INC - Q4 2020 holdings

$1.42 Billion is the total value of SECTORAL ASSET MANAGEMENT INC's 97 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 46.6% .

 Value Shares↓ Weighting
AVIR NewATEA PHARMACEUTICALS INC$62,340,0001,492,090
+100.0%
4.39%
ARVN SellARVINAS INC$45,193,000
+172.9%
532,125
-24.1%
3.18%
+123.7%
TNDM BuyTANDEM DIABETES CARE INC$45,144,000
+78.4%
471,818
+111.6%
3.18%
+46.2%
TDOC BuyTELADOC HEALTH INC$41,963,000
+64.5%
209,859
+80.4%
2.96%
+34.8%
LH BuyLABORATORY CORP AMER HLDGS$41,165,000
+25.2%
202,237
+15.8%
2.90%
+2.7%
PTCT SellPTC THERAPEUTICS INC$36,861,000
+17.8%
603,978
-9.8%
2.60%
-3.5%
EXEL BuyEXELIXIS INC$36,172,000
+72.7%
1,802,270
+110.4%
2.55%
+41.5%
ATRC SellATRICURE INC$35,864,000
+26.8%
644,217
-9.1%
2.53%
+3.9%
TFX BuyTELEFLEX INCORPORATED$35,474,000
+43.7%
86,193
+18.9%
2.50%
+17.8%
FOLD SellAMICUS THERAPEUTICS INC$35,434,000
+16.5%
1,534,604
-28.7%
2.50%
-4.5%
ACAD BuyACADIA PHARMACEUTICALS INC$34,985,000
+52.4%
654,414
+17.6%
2.46%
+24.9%
PPD BuyPPD INC$33,438,000
-6.1%
977,154
+1.5%
2.36%
-23.1%
EVH SellEVOLENT HEALTH INCcl a$32,834,000
+26.8%
2,048,257
-1.8%
2.31%
+4.0%
TPTX BuyTURNING POINT THERAPEUTICS I$31,362,000
+43.3%
257,379
+2.8%
2.21%
+17.5%
AFIB BuyACUTUS MED INC$28,298,000
+78.4%
982,236
+84.6%
1.99%
+46.3%
RCM SellR1 RCM INC$28,209,000
+6.8%
1,174,393
-23.8%
1.99%
-12.5%
DCPH BuyDECIPHERA PHARMACEUTICALS IN$27,898,000
+30.7%
488,842
+17.5%
1.97%
+7.1%
MRVI NewMARAVAI LIFESCIENCES HLDGS I$27,450,000978,600
+100.0%
1.93%
REPL NewREPLIMUNE GROUP INC$25,474,000667,729
+100.0%
1.80%
IRTC BuyIRHYTHM TECHNOLOGIES INC$25,278,000
+2.5%
106,565
+2.9%
1.78%
-16.0%
SILK BuySILK RD MED INC$25,159,000
-3.5%
399,483
+3.0%
1.77%
-20.9%
NVAX BuyNOVAVAX INC$24,906,000
+94.5%
223,350
+89.0%
1.76%
+59.4%
ALGN BuyALIGN TECHNOLOGY INC$24,662,000
+107.5%
46,150
+27.1%
1.74%
+70.1%
ARNA SellARENA PHARMACEUTICALS INC$24,590,000
-19.8%
320,059
-21.9%
1.73%
-34.3%
RGEN BuyREPLIGEN CORP$23,799,000
+58.2%
124,193
+21.8%
1.68%
+29.6%
IDXX BuyIDEXX LABS INC$23,693,000
+46.3%
47,399
+15.0%
1.67%
+20.0%
RCUS SellARCUS BIOSCIENCES INC$22,356,000
+41.3%
861,160
-6.7%
1.58%
+15.8%
CERT NewCERTARA INC$20,431,000605,900
+100.0%
1.44%
RCKT NewROCKET PHARMACEUTICALS INC$20,147,000367,385
+100.0%
1.42%
ZBH NewZIMMER BIOMET HOLDINGS INC$18,645,000121,000
+100.0%
1.31%
AMWL BuyAMERICAN WELL CORPcl a$18,342,000
+2.3%
724,120
+19.7%
1.29%
-16.1%
PRAH BuyPRA HEALTH SCIENCES INC$17,156,000
+27.5%
136,770
+3.1%
1.21%
+4.5%
MRTX NewMIRATI THERAPEUTICS INC$16,174,00073,638
+100.0%
1.14%
DXCM SellDEXCOM INC$15,699,000
-21.3%
42,463
-12.3%
1.11%
-35.5%
CNC SellCENTENE CORP DEL$15,399,000
-32.3%
256,515
-34.2%
1.08%
-44.5%
RVMD SellREVOLUTION MEDICINES INC$15,401,000
-30.1%
389,006
-38.6%
1.08%
-42.7%
BPMC SellBLUEPRINT MEDICINES CORP$15,308,000
-44.0%
136,500
-53.7%
1.08%
-54.1%
OSH NewOAK STR HEALTH INC$15,290,000250,000
+100.0%
1.08%
SRPT SellSAREPTA THERAPEUTICS INC$14,769,000
+14.0%
86,624
-6.1%
1.04%
-6.6%
RMD SellRESMED INC$14,094,000
+13.7%
66,305
-8.3%
0.99%
-6.8%
ALNY NewALNYLAM PHARMACUETICALS INC$14,082,000108,346
+100.0%
0.99%
ALXN BuyALEXION PHARMACEUTICALS INC$13,745,000
+134.2%
87,976
+71.6%
0.97%
+92.3%
MRNA SellMODERNA INC$13,195,000
+37.2%
126,306
-7.1%
0.93%
+12.5%
FRLN SellFREELINE THERAPEUTICS HLDGSsponsored ads$12,006,000
-8.7%
657,494
-22.0%
0.85%
-25.2%
JNJ  JOHNSON & JOHNSON$11,725,000
+5.7%
74,5000.0%0.83%
-13.4%
HOLX BuyHOLOGIC INC$11,529,000
+13.7%
158,300
+3.7%
0.81%
-6.9%
PODD SellINSULET CORP$10,904,000
+3.2%
42,654
-4.5%
0.77%
-15.4%
SGTX NewSIGILON THERAPEUTICS INC$10,807,000225,000
+100.0%
0.76%
TGTX NewTG THERAPEUTICS INC$10,745,000206,549
+100.0%
0.76%
ABBV BuyABBVIE INC$10,206,000
+35.1%
95,250
+10.4%
0.72%
+10.6%
SGEN NewSEAGEN INC$10,177,00058,106
+100.0%
0.72%
GH SellGUARDANT HEALTH INC$10,180,000
+13.3%
78,986
-1.7%
0.72%
-7.2%
PSTX SellPOSEIDA THERAPETUICS INC$9,202,000
-1.6%
838,826
-20.4%
0.65%
-19.4%
BMY SellBRISTOL-MYERS SQUIBB CO$9,030,000
-24.2%
145,574
-26.3%
0.64%
-37.9%
FATE NewFATE THERAPEUTICS INC$9,002,00099,000
+100.0%
0.63%
UNH  UNITEDHEALTH GROUP INC$8,929,000
+12.5%
25,4620.0%0.63%
-7.8%
CTSO SellCYTOSORBENTS CORP$8,806,000
-32.3%
1,104,935
-32.2%
0.62%
-44.5%
NTRA NewNATERA INC$8,753,00087,950
+100.0%
0.62%
ABT BuyABBOTT LABS$8,726,000
+8.8%
79,698
+8.1%
0.62%
-10.9%
LLY  LILLY ELI & CO$8,706,000
+14.1%
51,5650.0%0.61%
-6.6%
BMRN SellBIOMARIN PHARMACEUTICAL INC$8,486,000
-26.3%
96,772
-36.0%
0.60%
-39.6%
MOH SellMOLINA HEALTHCARE INC$8,076,000
-22.9%
37,972
-33.7%
0.57%
-36.8%
CMPI SellCHECKMATE PHARMACEUTICALS IN$8,007,000
+15.8%
548,802
-8.6%
0.56%
-5.1%
AVEO BuyAVEO PHARMACEUTICALS INC$6,642,000
+1018.2%
1,151,175
+1051.2%
0.47%
+817.6%
CI BuyCIGNA CORP NEW$5,775,000
+35.1%
27,741
+9.9%
0.41%
+10.6%
SEER NewSEER INC$5,315,00094,681
+100.0%
0.38%
BLU NewBELLUS HEALTH INC NEW$5,193,0001,696,940
+100.0%
0.37%
AMGN SellAMGEN INC$5,162,000
-16.6%
22,453
-7.8%
0.36%
-31.6%
TMO BuyTHERMO FISHER SCIENTIFIC INC$4,844,000
+26.8%
10,400
+20.2%
0.34%
+4.0%
MDT SellMEDTRONIC PLC$4,510,000
+3.9%
38,501
-7.8%
0.32%
-14.7%
VRTX BuyVERTEX PHARMACEUTICALS INC$3,999,000
+48.9%
16,921
+71.4%
0.28%
+22.1%
FGEN  FIBROGEN INC$3,857,000
-9.8%
104,0000.0%0.27%
-26.1%
CRSP NewCRISPR THERAPEUTICS AGnamen akt$3,823,00024,970
+100.0%
0.27%
APLS NewAPELLIS PHARMACEUTICALS INC$3,718,00065,000
+100.0%
0.26%
MRK SellMERCK & CO. INC$3,640,000
-13.1%
44,500
-11.9%
0.26%
-28.6%
PFE SellPFIZER INC$3,493,000
-15.0%
94,900
-15.2%
0.25%
-30.3%
NCNA  NUCANA PLCsponsored adr$3,368,000
-13.2%
750,0000.0%0.24%
-28.8%
BIIB SellBIOGEN INC$3,130,000
-51.2%
12,782
-43.5%
0.22%
-60.0%
REGN SellREGENERON PHARMCTICALS$2,232,000
-82.6%
4,620
-79.9%
0.16%
-85.8%
MTEM BuyMOLECULAR TEMPLATES INC$2,108,000
+7.6%
224,500
+25.1%
0.15%
-11.8%
SHC NewSOTERA HEALTH CO$2,048,00074,618
+100.0%
0.14%
SYK NewSTRYKER CORPORATION$1,911,0007,800
+100.0%
0.14%
BSX SellBOSTON SCIENTIFIC CORP$1,806,000
-87.5%
50,226
-86.7%
0.13%
-89.7%
GILD SellGILEAD SCIENCES INC$1,722,000
-58.0%
29,550
-54.5%
0.12%
-65.7%
DHR  DANAHER CORPORATION$1,666,000
+3.2%
7,5000.0%0.12%
-15.8%
ILMN SellILLUMINA INC$1,506,000
+0.6%
4,070
-16.0%
0.11%
-17.8%
APRE SellAPREA THERAPEUTICS INC$805,000
-96.3%
163,681
-82.1%
0.06%
-97.0%
INCY SellINCYTE CORP$752,000
-94.0%
8,640
-93.8%
0.05%
-95.1%
ARGX  ARGENX SEsponsored adr$735,000
+12.0%
2,5000.0%0.05%
-7.1%
HZNP NewHORIZON THERAPEUTICS PUB L$693,0009,475
+100.0%
0.05%
ZLAB BuyZAI LAB LTDadr$528,000
+134.7%
3,900
+44.4%
0.04%
+94.7%
ALGS NewALIGOS THERAPEUTICS INC$517,00018,708
+100.0%
0.04%
RDY BuyDR REDDYS LABS LTDadr$460,000
+23.7%
6,454
+20.5%
0.03%0.0%
BBIO NewBRIDGEBIO PHARMA INC$427,0006,000
+100.0%
0.03%
ALVR SellALLOVIR INC$375,000
-95.1%
9,746
-96.5%
0.03%
-96.0%
KOD NewKODIAK SCIENCES INC$242,0001,650
+100.0%
0.02%
FDMT New4D MOLECULAR THERAPEUTICS IN$217,0005,224
+100.0%
0.02%
CSTL ExitCASTLE BIOSCIENCES INC$0-18,500
-100.0%
-0.08%
GBIO ExitGENERATION BIO CO$0-35,000
-100.0%
-0.09%
HUM ExitHUMANA INC$0-2,666
-100.0%
-0.10%
CHNG ExitCHANGE HEALTHCARE INC$0-82,145
-100.0%
-0.10%
TRHC ExitTABULA RASA HEALTHCARE INC$0-35,177
-100.0%
-0.12%
OM ExitOUTSET MED INC$0-69,773
-100.0%
-0.30%
AMED ExitAMEDISYS INC$0-15,825
-100.0%
-0.32%
EBS ExitEMERGENT BIOSOLUTIONS INC$0-79,950
-100.0%
-0.71%
TSHA ExitTAYSHA GENE THERAPIES INC$0-373,775
-100.0%
-0.72%
DYN ExitDYNE THERAPEUTICS INC$0-474,301
-100.0%
-0.82%
SGEN ExitSEATTLE GENETICS INC$0-54,716
-100.0%
-0.92%
GBT ExitGLOBAL BLOOD THERAPEUTICS IN$0-255,271
-100.0%
-1.21%
ASMB ExitASSEMBLY BIOSCIENCES INC$0-916,185
-100.0%
-1.30%
ZNTL ExitZENTALIS PHARMACEUTICALS INC$0-556,712
-100.0%
-1.56%
HMSY ExitHMS HLDGS CORP$0-782,563
-100.0%
-1.61%
IMMU ExitIMMUNOMEDICS INC$0-600,242
-100.0%
-4.39%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-02-12
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
BIOMARIN PHARMAC INC42Q3 20236.7%
PTC THERAPEUTICS INC42Q3 20232.7%
DR REDDYS LABS LTD42Q3 20232.0%
GILEAD SCIENCES INC38Q3 20238.4%
INCYTE CORPORATION38Q3 20235.2%
VERTEX PHARMACEUTICL38Q3 20236.0%
AMICUS THERAPEUTICS INC37Q3 20236.6%
PFIZER INC35Q3 20236.3%
MERCK & CO. INC34Q3 20236.4%
MEDTRONIC PLC33Q3 20234.4%

View SECTORAL ASSET MANAGEMENT INC's complete holdings history.

Latest significant ownerships (13-D/G)

View SECTORAL ASSET MANAGEMENT INC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
13F-HR2023-11-14
13F-HR2023-08-11
13F-HR2023-05-12
SC 13G/A2023-02-13
SC 13G2023-02-13
13F-HR2023-02-10
13F-HR2022-11-10

View SECTORAL ASSET MANAGEMENT INC's complete filings history.

Compare quarters

Export SECTORAL ASSET MANAGEMENT INC's holdings